首頁 > 市場調查報告書 > 醫療設備

居家醫療

市場調查報告書

商品編碼

1588548

全球家庭醫療保健產業市場 - 2024-2031

Global Home Healthcare Industry Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年全球家庭醫療保健產業市場規模達2,695.3億美元，預估至2031年將達4,742.5億美元，2024-2031年預測期間複合年成長率為7.32%。

由於人口老化和慢性病盛行率上升，對家庭護理服務的需求不斷成長，全球家庭醫療保健行業市場正在迅速擴張。家庭醫療保健包括護理、物理治療、遠距醫療和輔助設備等各種服務。這種護理模式為患者提供了在家中接受醫療的便利，從而降低了住院的必要性並減少了醫療費用。

遠距醫療和遠距患者監護的廣泛採用進一步推動了該行業的成長，這些技術已成為管理糖尿病、心臟病和呼吸系統疾病等慢性病患者的重要工具。美國醫療保險和醫療補助服務中心 (CMS) 和世界衛生組織 (WHO) 制定的監管框架在標準化家庭醫療保健服務的品質和安全方面發揮了至關重要的作用。

由於老年人口的增加、技術的採用以及政府為減少醫院擁擠而做出的努力，亞太地區正在成為家庭醫療保健成長最快的市場之一。在政府促進居家養老的政策的支持下，日本、中國和印度等國家對家庭醫療保健服務的需求正在激增。日本是世界上人口老化最快的國家之一，在家庭醫療保健技術方面進行了大量投資。

動力學

技術進步和人口老化

科技創新加上全球人口老化是家庭醫療保健市場的關鍵驅動力。智慧顯示器、遠距醫療平台和穿戴式裝置等先進的醫療保健設備正在成為家庭醫療保健不可或缺的一部分。這些技術有助於慢性病的管理、減少去醫院次數並提高病患照護的整體效率。例如，穿戴式心臟監測器可以為醫療保健提供者提供即時更新，以便在必要時進行及時干預。

老年人口的增加是另一個主要驅動力。根據聯合國 (UN) 預測，2019 年至 2050 年間，全球 80 歲及以上人口數量預計將增加兩倍，從 1.43 億增至 4.26 億。這一特定人群的增加導致對家庭醫療保健服務的需求更大，因為老年人選擇在自己的家中接受護理，而不是長期住在醫院並承擔高額醫療費用。

不斷上漲的醫療成本和政府支持

醫療保健費用的不斷增加促使患者和醫療保健提供者尋求經濟的選擇，與醫院治療相比，家庭醫療保健可以節省大量成本。根據醫療保險和醫療補助服務中心 (CMS) 的說法，家庭醫療保健是管理慢性病和手術復健的經濟有效的選擇，因為它比醫院護理便宜得多。由於預算限制，醫療保健系統正在以報銷政策和稅收優惠的形式獲得更多政府援助，以促進家庭醫療保健服務的使用。

此外，美國勞工統計局預測，從 2020 年到 2030 年，家庭醫療保健產業的就業機會將增加 29%，超過所有職業的平均成長率，突顯該產業在醫療保健服務中的重要性日益增強。此外，此類政府努力對於推動市場向前發展至關重要，因為全球家庭醫療保健支出預計每年都會以顯著的速度成長。這種成長在人口老化和醫院系統不堪重負的國家尤其明顯。

勞動力短缺和監管挑戰

勞動力短缺和監管障礙是阻礙家庭醫療保健產業成長的關鍵因素。包括護士和助手在內的合格家庭保健人員的短缺給服務提供壓力，特別是在農村地區。世衛組織預計，到 2030 年，要加快全民健康覆蓋，將短缺 1,800 萬名衛生工作者，特別是在低收入和中低收入國家，這將加劇家庭醫療保健問題。

此外，監管挑戰也限制了市場成長。擁有嚴格醫療保健法規的國家可能在報銷流程、家庭醫療保健提供者的認證要求以及圍繞使用數位健康監測工具的隱私問題方面面臨障礙。這些監管瓶頸往往會減緩家庭醫療保健新技術和服務的採用。

The global home healthcare industry market is expanding rapidly due to the rising demand for in-home care services driven by an aging population and an increased prevalence of chronic diseases. Home healthcare includes a variety of services such as nursing care, physical therapy, telehealth and assistive devices. This care model provides patients with the convenience of receiving medical care at home, which in turn lowers the necessity for hospitalization and reduces healthcare expenses.

The industry's growth is further propelled by the widespread adoption of telemedicine and remote patient monitoring, which have become essential tools for managing patients with chronic conditions like diabetes, heart disease and respiratory disorders. Regulatory frameworks, such as those set by US Centers for Medicare & Medicaid Services (CMS) and the World Health Organization (WHO), have played a crucial role in standardizing quality and safety in-home healthcare services.

Asia-Pacific is becoming one of the fastest growing markets for home healthcare due to the increasing elderly population, adoption of technology and government efforts to decrease hospital congestion. Countries such as Japan, China and India are witnessing a surge in demand for home healthcare services, supported by government policies promoting elderly care at home. Japan, with one of the world's most rapidly aging populations, has seen significant investment in home healthcare technologies.

Dynamics

Technological Advancements and Aging Population

Technological innovations, coupled with the aging global population, are key drivers in the home healthcare market. Advanced healthcare devices such as smart monitors, telehealth platforms and wearable devices are becoming integral to in-home medical care. These technologies aid in the management of chronic conditions, lessen hospital trips and enhance overall efficiency in patient care. For instance, wearable heart monitors can offer healthcare providers instant updates, allowing for prompt interventions as necessary.

The increasing elderly population is another major driver. According to the United Nations (UN), the global number of people aged 80 years or older is expected to triple between 2019 and 2050, increasing from 143 million to 426 million. The increase in this specific demographic leads to a greater need for home healthcare services, as elderly people opt to be cared for in their own homes instead of staying in hospitals for long periods and incurring high healthcare expenses.

Rising Healthcare Costs and Government Support

The increasing expense of healthcare is driving patients and healthcare providers to seek economical options, with home healthcare providing substantial cost savings in comparison to hospital treatment. According to the Centers for Medicare & Medicaid Services (CMS), home healthcare is a cost-effective option for managing chronic diseases and recovering from surgeries, as it is notably cheaper than hospital care. With budget limitations, healthcare systems are gaining more government aid in the form of reimbursement policies and tax incentives to promote the use of home healthcare services.

Furthermore, US Bureau of Labor Statistics predicts a 29% increase in job opportunities within the home healthcare industry from 2020 to 2030, surpassing the average growth rate for all professions and highlighting the sector's increasing significance in healthcare services. Additionally, government efforts like these are essential for driving the market forward, as global healthcare expenditures on home healthcare are expected to increase with a notable growth rate each year. This increase is particularly noticeable in nations with elderly populations and overwhelmed hospital systems.

Workforce Shortages and Regulatory Challenges

Workforce shortages and regulatory hurdles are the key factors that hamper the growth of the home healthcare industry. A shortage of qualified home healthcare workers, including nurses and aides, is placing a strain on service delivery, especially in rural areas. WHO projects a shortfall of 18 million health workers to accelerate universal health coverage by 2030, particularly in low- and lower-middle-income countries, exacerbating the issue of home healthcare.

Additionally, regulatory challenges pose a restraint on market growth. Countries with stringent healthcare regulations may face barriers in terms of reimbursement processes, certification requirements for home healthcare providers and privacy concerns surrounding the use of digital health monitoring tools. These regulatory bottlenecks often slow down the adoption of new technologies and services in home healthcare.

Segment Analysis

The global home healthcare industry market is segmented based on offering, indication and region.

Demand for Assistive Devices and Remote Monitoring Tools

The demand for home healthcare market is driven by the adoption of assistive devices and remote monitoring tools. The devices help manage chronic diseases and enable elderly or disabled individuals to live more independently. According to the United Nations, the global population aged 60 years or over is expected to double by 2050, driving increased demand for devices like mobility aids, oxygen delivery systems and home dialysis equipment.

Telehealth and remote patient monitoring are also experiencing significant demand as they enable healthcare providers to monitor patient's conditions without the need for in-person visits. Furthermore, advancements in communication technologies and the increasing prevalence of chronic conditions such as diabetes and hypertension also drive the home health market growth. Moreover, these tools reduce the burden on healthcare systems by allowing for continuous monitoring and early intervention, which can help prevent hospital readmissions and improve overall patient outcomes.

Geographical Penetration

Demand for Home-Based Medical Services in North America

North America dominates the global home healthcare market, driven by a strong demand for home-based medical services, particularly for managing chronic diseases like cardiovascular disease (CVD) and cancer. According to the Centers for Disease Control and Prevention (CDC), heart disease accounted for 680,909 deaths in US in 2023, making it the third leading cause of death. With cancer (613,331 deaths) and unintentional injuries (222,518 deaths) also among the top causes, the need for at-home healthcare solutions for chronic disease management has intensified.

US healthcare system is increasingly adopting home healthcare solutions as a cost-effective alternative to hospital-based care. As healthcare costs continue to rise, patients are seeking home-based treatment options for post-surgery recovery and chronic disease management. US government's support, through reimbursement policies and tax incentives, further drives the adoption of home healthcare technologies and services.

Competitive Landscape

The major global players in the market include Omron Healthcare, Inc, 3M, Air Liquide, B. Braun Melsungen AG, Linde plc, GE HealthCare, Koninklijke Philips N.V., Dickinson and Company, A&D Company Limited and Addus HomeCare Corporation.

Sustainability Analysis

Sustainability is becoming an increasingly important factor in the global home healthcare industry, with a growing emphasis on reducing the environmental impact of medical waste and energy consumption. The adoption of energy-efficient medical equipment and telehealth tools is reducing the healthcare sector's carbon footprint, as digital healthcare technologies are decreasing the reliance on physical infrastructure.

According to the Global Sustainability Council for Healthcare (GSCH), the home healthcare market can contribute significantly to global sustainability goals by reducing the need for hospital infrastructure, thereby decreasing energy consumption and waste generation. Specifically, remote patient monitoring systems and telemedicine help decrease the need for patients to travel and be admitted to the hospital, supporting a more sustainable healthcare system. Furthermore, companies are increasingly focused on designing recyclable and biodegradable medical devices, aligning with global environmental regulations and consumer demand for eco-friendly solutions.

Russia-Ukraine War Impact

The ongoing Russia-Ukraine war has created both direct and indirect challenges for the global home healthcare industry. One of the main impacts has been the disruption of medical device and healthcare supply chains across Europe. Ukraine is an essential provider of electronic parts for medical equipment, including those for home medical care. The conflict has caused disruptions in the supply chain, resulting in shortages and higher prices for medical devices, which has in turn delayed the adoption of home healthcare technologies.

Moreover, with the geopolitical situation resulting in a significant humanitarian crisis, healthcare systems in neighboring countries have been overwhelmed by the influx of refugees. This situation has redirected healthcare resources, including home healthcare services, to crisis management. Furthermore, governments in impacted areas are increasing financial allocation to military expenses, possibly leading to a decrease in funding for healthcare, such as home healthcare initiatives.

By Offering

Services
- Physician primary care
- Nursing care
- Physical/occupational/speech therapy
- Nutritional support
- Unskilled Care
- Others
Products
- Therapeutic Products
- Testing, Screening and Monitoring Products
- Mobility Care Products
- Others

By Indication

Cancer
Neurological Disorders
Mobility Disorders
Diabetes
Cardiovascular Disorders
Others

Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In June 2023, Amedisys, a leading provider of personalized home health and hospice care, announced its agreement to combine with Optum, a diversified health services company. Amedisys provides specialized care to patients in their homes through over 11.2 million home visits each year. This merger is intended to improve the provision of complete home healthcare services, leading to better patient results and increasing their presence in the expanding home healthcare industry.
In February 2023, 3M launched a new medical adhesive designed for use with a variety of sensors, health monitors and long-term medical wearables. This strategic move helped 3M broaden its product offering in the home healthcare space, particularly in medical wearables, by catering to the growing demand for remote patient monitoring solutions.
In November 2022, the Pennant Group, Inc. acquired a Wisconsin-based home health provider to deliver skilled home health and community health services in Kenosha, Wisconsin. This acquisition reflects Pennant's strategy to strengthen its footprint in the home healthcare market.

Why Purchase the Report?

To visualize the global home healthcare industry market segmentation based on offering, indication and region.
Identify commercial opportunities by analyzing trends and co-development.
Excel spreadsheet containing a comprehensive dataset of the home healthcare industry market, covering all levels of segmentation.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global home healthcare industry market report would provide approximately 46 tables, 35 figures and 201 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Offering
3.2. Snippet by Indication
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements and Aging Population
  - 4.1.1.2. Rising Healthcare Costs and Government Support
- 4.1.2. Restraints
  - 4.1.2.1. Workforce Shortages and Regulatory Challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. By Offering

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 6.1.2. Market Attractiveness Index, By Offering
6.2. Services*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 6.2.2.1. Physician primary care
  - 6.2.2.2. Nursing care
  - 6.2.2.3. Physical/occupational/speech therapy
  - 6.2.2.4. Nutritional support
  - 6.2.2.5. Unskilled Care
  - 6.2.2.6. Others
6.3. Products
- 6.3.1. Introduction
- 6.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 6.3.2.1. Therapeutic Products
  - 6.3.2.2. Testing, Screening and Monitoring Products
  - 6.3.2.3. Mobility Care Products
  - 6.3.2.4. Others

7. By Indication

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 7.1.2. Market Attractiveness Index, By Indication
7.2. Cancer*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Neurological Disorders
7.4. Mobility Disorders
7.5. Diabetes
7.6. Cardiovascular Disorders
7.7. Others

8. Sustainability Analysis

8.1. Environmental Analysis
8.2. Economic Analysis
8.3. Governance Analysis

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. US
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Omron Healthcare, Inc*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. 3M
11.3. Air Liquide
11.4. B. Braun Melsungen AG
11.5. Linde plc
11.6. GE HealthCare
11.7. Koninklijke Philips N.V.,
11.8. Dickinson and Company
11.9. A&D Company Limited
11.10. Addus HomeCare Corporation.

LIST NOT EXHAUSTIVE